Pharmaceuticals

Plant-Based Vaccines Market Forecast 2026–2030 Presenting Long-Term Industry Insights

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Plant-Based Vaccines Market Over The 2026–2030 Period?

The plant-based vaccines market has seen swift expansion in recent years. It is projected to increase from $1.81 billion in 2025 to $1.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.2%. The historical growth can be attributed to several factors, including inadequate cold chain infrastructure in developing regions, the high expense of conventional vaccine production, the rising incidence of zoonotic diseases, initial academic research in plant molecular farming, and governmental support for alternative biologics.

The plant-based vaccines market size is projected to undergo substantial growth in the forthcoming years. It is anticipated to expand to $3.06 billion by 2030, driven by a compound annual growth rate (CAGR) of 11.3%. This expansion during the forecast period is attributable to an escalating demand for scalable vaccine platforms, an increase in pandemic preparedness initiatives, rising investments in plant biotechnology startups, the need for cost-effective veterinary vaccines, and developments in the regulatory landscape for novel vaccine platforms. Key trends anticipated during the forecast period encompass the broadening of recombinant antigen expression in plants, a heightened adoption of plant-based platforms for veterinary vaccines, an amplified focus on developing oral and edible vaccines, growing public and private financial support for alternative vaccine platforms, and advancements in downstream processing and purification technologies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

What Leading Drivers Are Supporting The Plant-Based Vaccines Market Expansion?

The widespread occurrence of infectious diseases is expected to propel the growth of the plant-based vaccines market going forward. These illnesses are caused by pathogenic microorganisms such as bacteria, viruses, or parasites, which can spread directly or indirectly and present significant health risks worldwide. The increasing number of infectious disease cases is driven by factors like greater global mobility, urban crowding, and weakened immunity in certain populations. Plant-based vaccines offer innovative platforms that can be rapidly scaled and adapted to address these rising health challenges. For instance, in March 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, the number of tuberculosis (TB) cases rose from 8,320 in 2022 to 9,615 in 2023, an increase of 1,295 cases. Therefore, the high prevalence of infectious diseases is driving the expansion of the plant-based vaccines market.

How Is The Plant-Based Vaccines Market Organized By Segment Classification?

The plant-based vaccines market covered in this report is segmented –

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:

1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines

2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines

3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines

4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

Which Trends Are Impacting The Progress Of The Plant-Based Vaccines Market?

Leading companies within the plant-based vaccines market are engaging in strategic manufacturing collaborations to expand clinical-stage production capabilities and hasten the advancement of next-generation VLP-based vaccines. These strategic manufacturing partnerships are designed to improve downstream processing efficiency, guarantee GMP-compliant manufacturing, and facilitate a seamless transition from early-stage research to clinical development. For instance, in December 2024, Aramis Biotechnologies Inc., a Canada-based company specializing in plant-based biomanufacturing of innovative vaccines, partnered with Biodextris Inc., a Canada-based CDMO specializing in cGMP complex biologic products, to support Phase 1 and Phase 2 clinical trials. Under this collaboration, the partner will perform purification, formulation, and fill-finish activities for plant-expressed VLP vaccine candidates, leading to faster scale-up, improved production quality, and strengthened readiness for advanced clinical evaluation.

Who Are The Industry Participants Involved In The Plant-Based Vaccines Market?

Major companies operating in the plant-based vaccines market are British American Tobacco PLC, Medicago Inc., Creative Biolabs Inc., Fraunhofer USA Inc., Biodextris Inc., Avesthagen Limited, Calyxt Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG, Zyus Life Sciences Inc., Agenus Inc.

Get The Full Plant-Based Vaccines Market Report:

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

Which Region Leads The Plant-Based Vaccines Market In Overall Market Size?

North America was the largest region in the plant-based vaccines market in 2025. The regions covered in the plant-based vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Plant-Based Vaccines Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

Browse Through More Reports Similar to the Global Plant-Based Vaccines Market 2026, By The Business Research Company

Plant Based Proteins Market 2026

https://www.thebusinessresearchcompany.com/report/plant-based-proteins-market

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Preventive Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/preventive-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795